PRP in infertility
Phase 2
Recruiting
- Conditions
- Evaluation of the effect of PRP on the outcome of IVF cycle in poorly responding patients.
- Registration Number
- IRCT20220809055651N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 15
Inclusion Criteria
This study will be conducted on 15 poor responder patients of group 3 and 1 poseidon. age less than 35 years, BMI less than 30 and AMH<1.2 ng/ml AFC<5 (group 3 Poseidon) or women under 35 years and a history of poor response during IVF cycle with AMH >1.2 ng/ml AFC >5 (Group 1 of Poseidon).
Exclusion Criteria
Hematological disorders (leukemia, thrombocytopenia), immunological disorders (antiphospholipid syndrome, thrombophilia), hormonal disorders (diabetes, thyroid, hyperprolactinemia), chromosomal and genetic abnormalities (hereditary or congenital) and kidney failure.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endometrial thickness. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Ultrasound.;Oocyte count. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Ultrasound (sonography).
- Secondary Outcome Measures
Name Time Method ANTI MOULLERIAN HORMON. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Measurement by blood test analysis after eight hours of fasting and without intimacy and stress the night before.;Follicle-stimulating Hormone. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Measurement by blood test analysis after eight hours of fasting and without intimacy and stress the night before.